ABX464: all 21 studies that test it

Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.

• Study to Evaluate Pharmacokinetics, Relative Bioavailability, Palatability of Obefazimod Minitablet FormulationRecruitingNCT07453784Phase 1
• Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's DiseaseRecruitingNCT06456593Phase 2
• ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2CompletedNCT05507216Phase 3Results posted
• ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1CompletedNCT05507203Phase 3Results posted
• ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19TerminatedNCT04393038Phase 2/3Results posted
• Efficacy and Safety Study of ABX464 as Maintenance Therapy in Patients With Moderate to Severe Ulcerative ColitisCompletedNCT04023396Phase 2Results posted
• Study of Two Doses of ABX464 in Participants With Moderate to Severe Rheumatoid ArthritisCompletedNCT03813199Phase 2Results posted
• Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative ColitisCompletedNCT03760003Phase 2Results posted
• Study Evaluating the Long-term Safety and Efficacy of ABX464 in Active Ulcerative ColitisCompletedNCT03368118Phase 2Results posted
• ABX464 in Subjects With Moderate to Severe Active Ulcerative ColitisCompletedNCT03093259Phase 2Results posted
• A Safety, Pharmacokinetics, and Pharmacodynamics Study of ABX464 in HIV-1 Seronegative and Seropositive AdultsCompletedNCT02990325Phase 1/2Results posted
• ABX464 in Fully Controlled HIV Infected Patients Treated With Boosted Protease Inhibitor TreatmentCompletedNCT02735863Phase 2Results posted
• ABTECT - MaintenanceActive, not recruitingNCT05535946Phase 3
• Long-term Safety and Efficacy Profile of ABX464 in Subjects With Moderate to Severe Active Ulcerative ColitisActive, not recruitingNCT05177835Phase 2
• Evaluation of the Potential CYP1A2-mediated Drug Drug Interaction Safety, and Tolerability of ABX464CompletedNCT05121714Phase 1
• Safety and Pharmacokinetics Study in Healthy Japanese VolunteersCompletedNCT05032560Phase 1
• Study Evaluating the Long-Term Safety and Efficacy of ABX464 in Patients With Moderate to Severe Rheumatoid ArthritisCompletedNCT04049448Phase 2
• Phase 2b/3 Study of ABX464 in Moderate to Severe Active Crohn's Disease PatientsWithdrawnNCT03905109Phase 2/3
• ABX464 First in Man StudyCompletedNCT02792686Phase 1
• Food Effect on Pharmacokinetic Parameters of ABX464CompletedNCT02731885Phase 1
• Safety, PK and PD Study of ABX464 in Untreated HIV PatientsCompletedNCT02452242Phase 2

← ABX464 overview